Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Felker, B. L. Articles by Barnes, R. F. Search for Related Content PubMed Citation Articles by Felker, B. L. Articles by Barnes, R. F. Anticonvulsants

The Safety of Valproic Acid Use for Patients With Hepatitis C Infection

OBJECTIVE: Valproic acid is frequently not recommended for patients with hepatic dysfunction. The authors evaluated the association between hepatitis C and alanine aminotransferase (ALT) values during valproic acid treatment. METHOD: ALT changes in 564 individuals beginning valproic acid treatment were examined. Changes among those with positive hepatitis C status were compared with changes among patients with positive hepatitis C status who were taking other psychotropic agents. RESULTS: ALT elevations with valproic acid were significantly greater among patients with positive hepatitis C status than those with negative or unknown status. Among patients with positive hepatitis C status, ALT increases did not differ significantly between valproic acid and other medications. CONCLUSIONS: Use of valproic acid may be possible for some patients with hepatitis C. ALT increases in seropositive patients may be partially related to chronic hepatitis infection. However, ALT levels should be closely monitored in all hepatitis C patients taking valproic acid.

This article has been cited by other articles:

				C. C. Crone, G. M. Gabriel, and A. DiMartini An Overview of Psychiatric Issues in Liver Disease for the Consultation-Liaison Psychiatrist Psychosomatics, June 1, 2006; 47(3): 188 - 205. [Abstract] [Full Text] [PDF]

				S. Armeanu, M. Bitzer, U. M. Lauer, S. Venturelli, A. Pathil, M. Krusch, S. Kaiser, J. Jobst, I. Smirnow, A. Wagner, et al. Natural Killer Cell-Mediated Lysis of Hepatoma Cells via Specific Induction of NKG2D Ligands by the Histone Deacetylase Inhibitor Sodium Valproate Cancer Res., July 15, 2005; 65(14): 6321 - 6329. [Abstract] [Full Text] [PDF]

				M. A. Rifai and D. L. Rosenstein Hepatitis C and Psychiatry Focus, April 1, 2005; 3(2): 194 - 202. [Abstract] [Full Text] [PDF]

				H.-M. Chang, M. Paulson, M. Holko, C. M. Rice, B. R. G. Williams, I. Marie, and D. E. Levy Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity PNAS, June 29, 2004; 101(26): 9578 - 9583. [Abstract] [Full Text] [PDF]

				C. U. Onyike, J. O. Bonner, C. G. Lyketsos, and G. J. Treisman Mania During Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin Am J Psychiatry, March 1, 2004; 161(3): 429 - 435. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us